Market Spotlight: CRISPR/Cas9

The 2016 Market for CRISPR/Cas9 Products & Services

Since the Doudna and Charpentier labs first realized the gene-editing capabilities of the CRISPR/Cas9 system, the field has expanded outward until it could be found in every corner of biological research. Whether it’s discovering oncogenes, tracking chromosomal recombination, building gRNA libraries, or identifying protein-binding domains for drug development, the versatility of CRISPR/Cas9 continues to captivate the scientific research community. It is this very captivation that has driven the surge in customer demand for CRISPR/Cas9 consumables and services over the past four years.

In order to understand the key elements driving this revolutionary field, BioInformatics LLC asked more than 1,350 scientists from around the world about their experience with CRISPR/Cas9 technology suppliers, including their brand perceptions, overall satisfaction, buying preferences, and preferred products. Our latest report—The 2016 Market for CRISPR/Cas9 Products & Services—includes their responses coupled with a wealth of valuable market information and derived metrics straight from the most important source: scientific customers.


Our 2016 report incorporates data from our 2015 survey and assembles it into accessible graphs and metrics for quick comparison. Based on these historical data, we are able to project market growth. For example, the scientists surveyed expect their budgets for CRISPR/Cas9 technology to grow by 35% over the next 12 months – this is nearly three times what we see in one of the mature markets we cover. With expansion of this magnitude, suppliers have the opportunity to quickly capture market share. In order to do so, companies need to gather the pertinent market information, especially with regards to the perception of their brand. As we demonstrate in our report, current use and loyalty are not mutually exclusive.

The 2016 report reflects the rapid changes occurring in this fast growing market. New sections added in this report includes:

  • Utilization of guide RNA libraries
  • Commercial suppliers of guide RNA libraries
  • Use of specialized Cas9 proteins
  • Techniques to ensure specificity of CRISPR genome editing
  • Use of CRISPR-related services


When it comes to maintaining a healthy brand, scientists are your greatest advocates. Their satisfaction with your company can quickly manifest as a promoting comment to a colleague or department, perhaps to one of the 16% who are in search of a new supplier of CRISPR/Cas9 technology. Conversely, a scathing review from a dissatisfied customer puts your brand in jeopardy of garnering the wrong sort of reputation. The reputation you create for your company becomes the single most important driver of new business. In a fast-growing, dynamic market like CRISPR, smaller, innovative companies have an opportunity to demonstrate their expertise and win share before the industry’s giants establish themselves.


Relative to 2015, leading causes of customer satisfaction remain unchanged. Cost, product quality, and technical support are the strongest drivers of switching behavior. However, regional differences in the value placed on each metric are striking. While European labs using CRISPR are more forgiving of poor technical support, 61% of scientists in Asia consider it to be the reason to switch suppliers. Regional trends should influence strategic marketing, with successful campaigns being regionally attuned and highly adaptable to customer expectations and preferences. BioInformatics LLC’s 2016 report consolidates end-user data on the CRISPR/Cas9 market into an easily navigated format and gives you the choice to develop custom presentations by region, market segment, and by brand for 20 leading suppliers to this fast growing market.